Home/Filings/4/0001209191-24-003198
4//SEC Filing

Burgess Justin 4

Accession 0001209191-24-003198

CIK 0001029142other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 5:21 PM ET

Size

9.2 KB

Accession

0001209191-24-003198

Insider Transaction Report

Form 4
Period: 2024-02-10
Burgess Justin
VP Finance & CAO
Transactions
  • Tax Payment

    Common Stock

    2024-02-12$12.82/sh2,499$32,0379,136 total
  • Exercise/Conversion

    Common Stock

    2024-02-10+6,66711,635 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-106,6676,666 total
    Common Stock (6,667 underlying)
Footnotes (4)
  • [F1]Code M: Exercise or conversion of derivative security
  • [F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
  • [F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
  • [F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1
  • filerCIK 0001812025

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:21 PM ET
Size
9.2 KB